Antifungal De-Escalation Is Safe in Critically Ill Patients Treated For Suspected Or Documented Invasive Candidiasis. Data From The Amarcand2 Study

0 avis

Antifungal De-Escalation Is Safe in Critically Ill Patients Treated For Suspected Or Documented Invasive Candidiasis. Data From The Amarcand2 Study

Archive ouverte

Edité par CCSD ; Springer -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units

Archive ouverte | Montravers, P. | CCSD

International audience

Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units

Archive ouverte | Montravers, P. | CCSD

International audience. OBJECTIVE:The clinical characteristics and prognosis of patients treated for Candida peritonitis (CP) were compared according to the type of systemic antifungal therapy (SAT), empiric (EAF) o...

Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units

Archive ouverte | Montravers, P. | CCSD

International audience

Chargement des enrichissements...